iRhythm Technologies (IRTC) Leads Cardiac Monitoring Market with Zio Device, Freedom Capital Initiates Coverage

iRhythm Technologies, Inc. (NASDAQ:IRTC) ranks among the best medical device stocks to invest in. On October 13, Freedom Capital Markets began coverage of iRhythm Technologies, Inc. (NASDAQ:IRTC) with a Buy rating and a $205 price target. Jirsak/Shutterstock.com With a 70% market share in long-term cardiac monitoring, Freedom Capital states that iRhythm’s Zio Monitor has established itself as a “category killer” and has disrupted the conventional 48-hour Holter monitors. According to Freedom Capital, i ...